Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure

Clinical trial NCT02775539 · UNKNOWN

Trial details

NCT number: NCT02775539
Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Hypertension Mirabegron Heart Failure Pulmonary Vascular Resistance Abnormality

Start date: 2016-06-01
Primary completion: 2017-01-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.